A Cheirsilpa

757 total citations
14 papers, 601 citations indexed

About

A Cheirsilpa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, A Cheirsilpa has authored 14 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in A Cheirsilpa's work include Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (2 papers) and Nausea and vomiting management (2 papers). A Cheirsilpa is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), RNA modifications and cancer (2 papers) and Nausea and vomiting management (2 papers). A Cheirsilpa collaborates with scholars based in Thailand, Malaysia and Indonesia. A Cheirsilpa's co-authors include T Azhar, Daniel T. T. Chua, Yupa Sumitsawan, Jonathan S. T. Sham, Sumitra Thongprasert, Ary Harryanto Reksodiputro, Damon Choy, Martin H.N. Tattersall, Vicharn Lorvidhaya and Sokbom Kang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Lung Cancer.

In The Last Decade

A Cheirsilpa

11 papers receiving 577 citations

Peers

A Cheirsilpa

SURGE

OTORH

ONCOL

PRM

Bok Ai Choo Singapore

Ang Qu China

Yeh You Shen Taiwan

Sallie S. Frankel United States

Xia He China

T Kowalska Poland

S. Vasanthan United Kingdom

Mina Yu South Korea

Roberto Almeida Gil Brazil

Hee Rim Nam South Korea

Bok Ai Choo Singapore

A Cheirsilpa

160 ×0.4

SURGE

43 ×0.1

OTORH

98 ×0.4

ONCOL

144 ×1.0

PRM

69 ×0.5

Citations per year, relative to A Cheirsilpa A Cheirsilpa (= 1×) peers Bok Ai Choo

Countries citing papers authored by A Cheirsilpa

Since Specialization

Citations

This map shows the geographic impact of A Cheirsilpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Cheirsilpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Cheirsilpa more than expected).

Fields of papers citing papers by A Cheirsilpa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Cheirsilpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Cheirsilpa. The network helps show where A Cheirsilpa may publish in the future.

Co-authorship network of co-authors of A Cheirsilpa

This figure shows the co-authorship network connecting the top 25 collaborators of A Cheirsilpa. A scholar is included among the top collaborators of A Cheirsilpa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Cheirsilpa. A Cheirsilpa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Cheirsilpa, A, et al.. (2011). P138 Prognostic factors of triple-negative breast cancer. The Breast. 20. S26–S27.

Cheirsilpa, A, et al.. (2005). Comparison of Ramosetron and Granisetron for the Prevention of Acute and Delayed Emesis in Cisplatin-Based Chemotherapy: a Randomized Controlled Trial. Japanese Journal of Clinical Oncology. 35(12). 695–699. 12 indexed citations

Sriplung, Hutcha, et al.. (2005). Cancer incidence in Thailand, 1995-1997.. PubMed. 6(3). 276–81. 46 indexed citations

Sangrajrang, Suleeporn, et al.. (2003). Serum p53 antibodies in correlation to other biological parameters of breast cancer. Cancer Detection and Prevention. 27(3). 182–186. 21 indexed citations

Cheirsilpa, A, et al.. (2001). Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Lung Cancer. 31(2-3). 257–265. 19 indexed citations

Sirachainan, Ekaphop, et al.. (2000). Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report.. PubMed. 83(1). 85–92. 5 indexed citations

Cheirsilpa, A, et al.. (1999). Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. Lung Cancer. 26(3). 175–185. 16 indexed citations

Chua, Daniel T. T., Jonathan S. T. Sham, Damon Choy, et al.. (1998). Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 83(11). 2270–2283. 226 indexed citations

Chua, Daniel T. T., Jonathan S. T. Sham, Damon Choy, et al.. (1998). Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 83(11). 2270–2283. 99 indexed citations

10.

Cheirsilpa, A, et al.. (1996). Immunohistochemical detection of c-erbB-2 oncoprotein in patients with breast cancer.. PubMed. 79(11). 715–21. 3 indexed citations

11.

Tattersall, Martin H.N., Vicharn Lorvidhaya, A Cheirsilpa, et al.. (1995). Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association.. Journal of Clinical Oncology. 13(2). 444–451. 144 indexed citations

12.

Cheirsilpa, A, et al.. (1994). Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.. PubMed. 77(4). 201–6.

13.

Cheirsilpa, A, et al.. (1992). Primary chemotherapy for locally advanced uterine cervical carcinoma.. PubMed. 19(8 Suppl). 1224–32. 1 indexed citations

14.

Cheirsilpa, A, et al.. (1989). High-dose mitomycin C: activity in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 24(1). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact